-
1
-
-
0030667339
-
α-secretase-derived product of β-amyloid precursor protein is decreased by presenilin-1 mutations linked to familial Alzheimer's disease
-
Ancolio K, Marambaud P, Dauch P, Checler F. α-secretase-derived product of β-amyloid precursor protein is decreased by presenilin-1 mutations linked to familial Alzheimer's disease. J Neurochem 1997; 69:2494-9.
-
(1997)
J Neurochem
, vol.69
, pp. 2494-2499
-
-
Ancolio, K.1
Marambaud, P.2
Dauch, P.3
Checler, F.4
-
2
-
-
0027435535
-
Protein phosphorylation inhibits production of the Alzheimer amyloid β/A4 peptide
-
Buxbaum JD, Koo EH, Greengard P. Protein phosphorylation inhibits production of the Alzheimer amyloid β/A4 peptide. Proc Natl Acad Sci USA 1993;90:9195-8.
-
(1993)
Proc Natl Acad Sci USA
, vol.90
, pp. 9195-9198
-
-
Buxbaum, J.D.1
Koo, E.H.2
Greengard, P.3
-
3
-
-
0028972701
-
Image analysis of β-amyloid load in Alzheimer's disease and relation to dementia severity
-
Cummings BJ, Cotman CW. Image analysis of β-amyloid load in Alzheimer's disease and relation to dementia severity. Lancet 1995; 346:1524-8.
-
(1995)
Lancet
, vol.346
, pp. 1524-1528
-
-
Cummings, B.J.1
Cotman, C.W.2
-
4
-
-
0030464914
-
β-amyloid deposition and other measures of neuropathology predict cognitive status in Alzheimer's disease
-
Cummings BJ, Pike CJ, Shankle R, Cotman CW. β-amyloid deposition and other measures of neuropathology predict cognitive status in Alzheimer's disease [see comments]. Neurobiol Aging 1996;17:92133.
-
(1996)
Neurobiol Aging
, vol.17
, pp. 92133
-
-
Cummings, B.J.1
Pike, C.J.2
Shankle, R.3
Cotman, C.W.4
-
5
-
-
0030669036
-
The pathogenesis of senile plaques
-
Dickson DW. The pathogenesis of senile plaques. J Neuropathol Exp Neurol 1997;56:321-39.
-
(1997)
J Neuropathol Exp Neurol
, vol.56
, pp. 321-339
-
-
Dickson, D.W.1
-
6
-
-
0030068094
-
+ channels and suppression of neuronal activity by secreted β-amyloid precursor protein
-
+ channels and suppression of neuronal activity by secreted β-amyloid precursor protein. Nature 1996;379:74-8.
-
(1996)
Nature
, vol.379
, pp. 74-78
-
-
Furukawa, K.1
Barger, S.W.2
Blalock, E.3
Mattson, M.P.4
-
7
-
-
0029841562
-
Increased activity-regulating and neuroprotective efficacy of α-secretase-derived secreted APP is conferred by a C-terminal heparin-binding domain
-
Furukawa K, Sopher B, Rydel RE, Begley JG, Martin GM, Mattson MP. Increased activity-regulating and neuroprotective efficacy of α-secretase-derived secreted APP is conferred by a C-terminal heparin-binding domain. J Neurochem 1996;67:1882-96.
-
(1996)
J Neurochem
, vol.67
, pp. 1882-1896
-
-
Furukawa, K.1
Sopher, B.2
Rydel, R.E.3
Begley, J.G.4
Martin, G.M.5
Mattson, M.P.6
-
8
-
-
0032524319
-
Secreted APPα counteracts the pro-apoptotic action of mutant presenilin-1 by activation of NF-kB and stabilization of calcium homeostasis
-
Guo Q, Robinson N, Mattson MP. Secreted APPα counteracts the pro-apoptotic action of mutant presenilin-1 by activation of NF-kB and stabilization of calcium homeostasis J Biol Chem 1998;273: 12341-51.
-
(1998)
J Biol Chem
, vol.273
, pp. 12341-12351
-
-
Guo, Q.1
Robinson, N.2
Mattson, M.P.3
-
9
-
-
0028179341
-
Chemical characterization of Aβ 17-42 peptide, a component of diffuse amyloid deposits of Alzheimer disease
-
Gowing E, Roher AE, Woods AS, et al. Chemical characterization of Aβ 17-42 peptide, a component of diffuse amyloid deposits of Alzheimer disease. J Biol Chem 1994;269:10987-90.
-
(1994)
J Biol Chem
, vol.269
, pp. 10987-10990
-
-
Gowing, E.1
Roher, A.E.2
Woods, A.S.3
-
10
-
-
0027535111
-
β-Amyloid peptide and a 3-kDa fragment are derived by distinct cellular mechanisms
-
Haass C, Hung AY, Schlossmacher MG, Teplow DB, Selkoe DJ. β-Amyloid peptide and a 3-kDa fragment are derived by distinct cellular mechanisms. J Biol Chem 1993;268:3021-4.
-
(1993)
J Biol Chem
, vol.268
, pp. 3021-3024
-
-
Haass, C.1
Hung, A.Y.2
Schlossmacher, M.G.3
Teplow, D.B.4
Selkoe, D.J.5
-
11
-
-
0026065826
-
Analysis and quantitation of the β-amyloid precursor protein in the cerebrospinal fluid of Alzheimer's disease patients with a monoclonal antibody-based immunoassay
-
Henriksson T, Barbour RM, Braa S, et al. Analysis and quantitation of the β-amyloid precursor protein in the cerebrospinal fluid of Alzheimer's disease patients with a monoclonal antibody-based immunoassay. J Neurochem 1991;56:1037-42.
-
(1991)
J Neurochem
, vol.56
, pp. 1037-1042
-
-
Henriksson, T.1
Barbour, R.M.2
Braa, S.3
-
12
-
-
0030035922
-
P3 β-amyloid peptide has a unique and potentially pathogenic immunohistochemical profile in Alzheimer's disease brain
-
Higgins LS, Murphy GM, Jr, Forno LS, Catalano R, Cordell B. P3 β-amyloid peptide has a unique and potentially pathogenic immunohistochemical profile in Alzheimer's disease brain. Am J Pathol 1996; 149:585-96.
-
(1996)
Am J Pathol
, vol.149
, pp. 585-596
-
-
Higgins, L.S.1
Murphy Jr., G.M.2
Forno, L.S.3
Catalano, R.4
Cordell, B.5
-
13
-
-
0030797332
-
Secreted form of β-amyloid precursor protein shifts the frequency dependence for induction of LTD, and enhances LTP in hippocampal slices
-
Ishida A, Furukawa K, Keller JN, Mattson MP. Secreted form of β-amyloid precursor protein shifts the frequency dependence for induction of LTD, and enhances LTP in hippocampal slices. Neuro-Report 1997;8:2133-7.
-
(1997)
Neuro-Report
, vol.8
, pp. 2133-2137
-
-
Ishida, A.1
Furukawa, K.2
Keller, J.N.3
Mattson, M.P.4
-
14
-
-
0031584845
-
Reduction of plasma glutamyl aminopeptidase activity in sporadic Alzheimer's disease
-
Kuda T, Shoji M, Arai H, Kawashima S, Saido TC. Reduction of plasma glutamyl aminopeptidase activity in sporadic Alzheimer's disease. Biochem Biophys Res Commun 1997:231:526-30.
-
(1997)
Biochem Biophys Res Commun
, vol.231
, pp. 526-530
-
-
Kuda, T.1
Shoji, M.2
Arai, H.3
Kawashima, S.4
Saido, T.C.5
-
15
-
-
0030300022
-
The nonamyloidogenic p3 fragment (amyloid β17-42) is a major constituent of Down's syndrome cerebellar preamyloid
-
Lalowski M, Golabek A, Lemere CA, et al. The "nonamyloidogenic" p3 fragment (amyloid β17-42) is a major constituent of Down's syndrome cerebellar preamyloid. J Biol Chem 1996;271:33623-31.
-
(1996)
J Biol Chem
, vol.271
, pp. 33623-33631
-
-
Lalowski, M.1
Golabek, A.2
Lemere, C.A.3
-
16
-
-
0032815498
-
Hypothesis: Amyloid β-peptides truncated at the N-terminus contribute to the pathogenesis of Alzheimer's disease
-
Lamer AJ. Hypothesis: amyloid β-peptides truncated at the N-terminus contribute to the pathogenesis of Alzheimer's disease. Neurobiol Aging 1999;20:65-69.
-
(1999)
Neurobiol Aging
, vol.20
, pp. 65-69
-
-
Lamer, A.J.1
-
17
-
-
0032501149
-
Alzheimer's disease-linked mutation of presenilin 2 (N141I-PS2) drastically lowers APPa secretion: Control by the proteasome
-
Marambaud P, Alves da Costa C, Ancolio K, Checler F. Alzheimer's disease-linked mutation of presenilin 2 (N141I-PS2) drastically lowers APPa secretion: control by the proteasome. Biochem Biophys Res Commun 1998;252:134-8.
-
(1998)
Biochem Biophys Res Commun
, vol.252
, pp. 134-138
-
-
Marambaud, P.1
Alves Da Costa, C.2
Ancolio, K.3
Checler, F.4
-
18
-
-
0027478347
-
Evidence for excitoprotective and intraneuronal calcium-regulating roles for secreted forms of β-amyloid precursor protein
-
Mattson MP, Cheng B, Culwell A, Esch F, Lieberburg I, Rydel RE. Evidence for excitoprotective and intraneuronal calcium-regulating roles for secreted forms of β-amyloid precursor protein. Neuron 1993; 10:243-54.
-
(1993)
Neuron
, vol.10
, pp. 243-254
-
-
Mattson, M.P.1
Cheng, B.2
Culwell, A.3
Esch, F.4
Lieberburg, I.5
Rydel, R.E.6
|